ArticlePDF Available

Molecular and cytogenetic characterization of human albumin transgenic goat fibroblasts as a source of nuclei in somatic cloning

Authors:

Abstract

Production of biopharmaceuticals in the mammary gland of domestic animals constitutes an important field of research in contemporary biotechnology. The objective of our investigations was to obtain goat transgenic fibroblast cells transfected with the assistance of the human albumin gene (pWAPhAlb) by the lipofection method for the needs of somatic cloning and to determine their molecular and cytogenetic characteristics. Transfection was carried out on 24 lines of goat fibroblasts and 19 lines in which integration of the introduced DNA was confirmed on the molecular level (PCR) were obtained. The method effectiveness reached 80%. Karyotype analysis (trypsin digestion, Giemsa stain) failed to show any changes in the chromosome number and structure(2n = 60, XX).
Ann. Anim. Sci., Vol. 11, No. 1 (2011) 61–70
MOLECULAR AND CYTOGENETIC CHARACTERIZATION
OF HUMAN ALBUMIN TRANSGENIC GOAT FIBROBLASTS
AS A SOURCE OF NUCLEI IN SOMATIC CLONING* *
11,22,
223,
31,2
1
2

3

Abstract
Production of biopharmaceuticals in the mammary gland of domestic animals constitutes an im-
portant field of research in contemporary biotechnology. The objective of our investigations was to
obtain goat transgenic fibroblast cells transfected with the assistance of the human albumin gene
(pWAPhAlb) by the lipofection method for the needs of somatic cloning and to determine their
molecular and cytogenetic characteristics. Transfection was carried out on 24 lines of goat fibrob-
lasts and 19 lines in which integration of the introduced DNA was confirmed on the molecular
level (PCR) were obtained. The method effectiveness reached 80%. Karyotype analysis (trypsin
digestion, Giemsa stain) failed to show any changes in the chromosome number and structure
(2n = 60, XX).
Key words: albumin, fibroblasts, transfection, nuclear transfer






             


A. Woźniak et al.



   



      
      


       
Capra hircus 










     

     
   



ALB

   


       


Material and methods

  

Characterization of human albumin transgenic goat fibroblasts 



  
2


32
   
           


  Aat 
Sph   
   
   
AatSph


  
    Sph  ClaI
    Sph  EcoR     

 Sph 
  ClaEcoR








  
    

           








A. Woźniak et al.







Characterization of human albumin transgenic goat fibroblasts 
 pWAPhAlb

       

      
pWAPhAlb




  




      

     

   






       
 
 


Results


         
          






A. Woźniak et al.


pWAPhAlb







pWAPhAlb


pWAPhAlb

Characterization of human albumin transgenic goat fibroblasts 
Discussion
      

            
     









           
     

 
    

















  

    

   

  

A. Woźniak et al.


        
        


 

        


Competing interests

References

                                


  
           

                                             
                       


                                      
       


               

                                  


                               



             


                    

                                


                          

Characterization of human albumin transgenic goat fibroblasts 
           
                                

            


               

                                


            

                                          


                        

   

                  


                     


                          


         

                                      
   


                

                               
    




Molekularna i cytogenetyczna charakterystyka transgenicznych fibroblastów kozy transfeko-
wanych ludzkim genem albuminy jako źródła jąder komórkowych w klonowaniu somatycznym


    


  

         

A. Woźniak et al.

ResearchGate has not been able to resolve any citations for this publication.
Article
Full-text available
This chapter reviews the use of genetically modified animals and the increasingly detailed knowledge of the genomes of the domestic species. The different approaches to genetic modification are outlined as are the advantages and disadvantages of the techniques in different species. Genetically modified mice have been fundamental in understanding gene function and in generating affordable models of human disease although these are not without their drawbacks. Transgenic farm animals have been developed for nutritionally enhanced food, disease resistance and xenografting. Transgenic rabbits, goats, sheep and cows have been developed as living bioreactors producing potentially high value biopharmaceuticals, commonly referred to as "pharming". Domestic animals are also important as a target as well as for testing genetic-based therapies for both inherited and acquired disease. This latter field may be the most important of all, in the future development of novel therapies.
Article
Full-text available
We have developed a method for production of transgenic chickens by DNA microinjection of chick zygotes followed by ex vivo embryo culture. The fate of plasmid DNA microinjected into the germinal disc of zygotes was analyzed in embryos which survived for at least 12 days in culture. Approximately half of the embryos contained plasmid DNA, 6% at a level equivalent to one copy per cell in all tissues analyzed. Seven chicks, 5.5% of the total number of injected ova, survived to sexual maturity. One of these, a cockerel, transmitted the exogenous DNA to 3.4% of his offspring. These G1 birds have reached sexual maturity and have been bred to produce transgenic offspring, demonstrating that stable transmission of foreign DNA can be obtained by our method.
Article
Full-text available
The gene construct WAP(6xHisThr):hGH containing the entire human growth hormone gene (hGH) under the rat whey acidic protein (WAP) promoter regulating the expression in mammary glands of mammals was prepared. The 5' end of the gene was modified by the addition of a sequence encoding six histidine residues and a sequence recognized by thrombin. The gene construct was introduced by microinjection into the male pronucleus of a fertilized oocyte. The founder male rabbit was obtained with the transgene mapping to chromosome 7. The presence of the growth hormone was confirmed in samples of milk collected during the lactation of F1 generation females. The growth hormone can be easily purified by affinity chromatography and cleavage by thrombin to an active form.
Article
The study aimed at obtaining the heifer's transgenic cell lines with integrated human interferon alpha gene (IFNα) having in view cloning of Polish Red cattle. The gene construct used (pbLGIFN-GFPBsd) contained the entire human interferon alpha gene under the bovine β-lactoglobulin promoter (bLG) and the green fluorescent protein gene (gfp) fused to the blasticidin resistance gene (bsd) under the human cytomegalovirus (CMV) immediate-early promoter. The gene construct was introduced by lipofection into heifer's ear fibroblasts. The GFP- and Bsd-positive cell lines have been obtained. The molecular analysis (PCR) and cytogenetic characterization (FISH) confirmed obtaining the stable heifer's transgenic cell lines with integrated human IFNα gene.
Article
The administration of purified human plasma-derived butyrylcholinesterase (HuBuChE) as a pretreatment has been demonstrated to enhance survival and protect against decreased cognitive function after exposure to organophosphorus poisons (OPs). Based on efficacy data obtained with guinea pigs and non-human primates and the lack of behavioral side effects, plasma-derived HuBuChE has been granted investigational new drug status by the US Food and Drug Administration. The recent availability of a recombinant form of HuBuChE (rHuBuChE) from the milk of transgenic goats has now allowed us to determine the pharmacokinetics of that material in guinea pigs and use it as a therapy following exposure to the VX. The rHuBuChE was expressed as a dimer and following intramuscular (i.m.) administration had more a rapid adsorption and clearance profile in guinea pigs than the plasma-derived material. Based on those data, we administered rHuBuChE i.m. 1h after a percutaneous exposure of guinea pigs to either 2xLD(50) or 5xLD(50) of VX. Post-exposure therapy with rHuBuChE provided improved survival at both challenge levels, 90% and 33% respectively versus 20% or 0% respectively for animals that did not receive therapy. These studies showed that BuChE can be efficacious as a therapy against percutaneous exposure to VX.
Article
Expression of recombinant human lysosomal acid beta-glucosidase (hGCase) by a transgenic animal bioreactor, using somatic cell nuclear transfer (SCNT), would decrease the cost of producing this product. The objective was to establish an effective procedure to prepare hGCase transgenic donor cells and nuclear transfer (NT) embryos to produce hGCase protein in the Saanen dairy goat mammary gland. A mammary-specific expression vector for hGCase was constructed and transfected into HC-11 mammary epithelial cells for bioactivity analysis in vitro; mRNA transcripts and hGCase protein were correctly expressed in transfected HC-11 cells. The hGCase gene was then introduced into fetal fibroblasts (from dairy goats) to prepare competent transgenic donor cells. Transgenic fibroblast clones from a single round of transfection were reliably isolated by 96-well cell culture plates and screened with PCR amplification and chromosomal counting (66.8%). Dairy goat cloned embryos were produced from these hGCase fetal cells by SCNT, the hGCase transgene was successfully detected in these embryos, and there were similar rates (P>0.05) of fusion (83.3% vs. 77.8%), cleavage (89.1% vs. 90.9%), and development to the morula/blastocyst stages (36.4% vs. 38.9%) between NT embryos using transgenic fetal fibroblasts and non-transfected control cells. Moreover, 98 well-developed reconstructed embryos derived from transgenic cells were transferred to 16 recipients; pregnancy was confirmed at 40 d in two goats. Therefore, we achieved functional expression of hGCase in mammary gland cells and normal development to Day 40 of cloned embryos carrying the hGCase gene.
Article
The use of nucleus transfer techniques to generate transgenic dairy goats capable of producing recombinant therapeutic proteins in milk could have a major impact on the pharmaceutical industry. However, transfection or gene targeting of nucleus transfer donor cells requires a long in vitro culture period and the selection of marker genes. In the current study, we evaluated the potential for using caprine mammary gland epithelial cells (CMGECs), isolated from udders of lactating F1 hybrid goats (Capra hircus) and cryopreserved at Passages 24 to 26, for nucleus transfer into enucleated in vivo-matured oocytes. Pronuclear-stage reconstructed embryos were transferred into the oviducts of 31 recipient goats. Twenty-three (74%), 21 (72%), and 14 (48%) recipients were confirmed pregnant by ultrasonography on Days 30, 60, and 90, respectively. Four recipients aborted between 35 and 137 d of gestation. Five recipients carried the pregnancies to term and delivered one goat kid each, one of which subsequently died due to respiratory difficulties. The remaining four goat kids were healthy and well. Single-strand conformation polymorphism analysis confirmed that all kids were clones of the donor cells. In conclusion, the CMGECs remained totipotent for nucleus transfer.
Article
Three transgenic females from a first generation transgenic male were induced to lactate between 11 and 12 months of age using a series of estrogen and progesterone injections. The milk contained human longer acting tissue plasminogen activator (LAtPA) at comparable concentrations (1-3 mg/ml) as occurred in the original founder female. In addition, the transgenic male was induced with a hormonal regime and was shown to produce 0.85 mg/ml of LAtPA. Milk protein gels indicated that the milk products (casein, IgG) were essentially normal. These experiments show that expression data for this vector can be evaluated in a shorter period of time in dairy goats than would be required through normal gestation and lactation schedules and can be used to identify the relative expression of transgenes in mammary tissue that would occur during normal lactation.
Article
A uromodulin promoter has been isolated, sequenced, and used to generate two sets of transgenic mice for expression of the lacZ marker gene and for production of the human recombinant erythropoietin (rhEPO) in urine. We demonstrated that the 5.6-kb fragment of the uromodulin gene containing the 3.7-kb promoter area and, both the first exon and part of the second exon, were sufficient to provide kidney-specific expression of the lacZ gene. Histological analysis of the lacZ expression pattern revealed beta-galactosidase activity specifically in the thick limb of Henle's loop. However, due to random integration of the transgene, ectopic expression was detected in some transgenic lines. Analysis of the EPO-transgenic mice showed that rhEPO was secreted into the urine of founder mice (up to 6 ng/ml). We were able to breed and analyze only two sublines with a very low expression level of rhEPO (up to 260 pg/ml). All of our transgenic mice expressing rhEPO in urine developed disease symptoms similar to polycythemia in humans. These included a considerable increase in red blood cell counts, hemoglobin concentration, and hematocrit concomitant with severe thrombocytopenia, all of which were detected in the rhEPO-expressing mice. Although our model did not prove to be beneficial for commercial production of rhEPO, we concluded that the uromodulin promoter could be useful for expression of other important therapeutic proteins into the urine of transgenic animals.